Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
Is a |
Product containing polymyxin B (medicinal product) |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
Is a |
Product containing hydrocortisone (medicinal product) |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
Is a |
Hydrocortisone-containing product in otic dose form |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Polymyxin B (substance) |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antiinfektiøst middel til huden |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone (substance) |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
binyrehormonmiddel |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
Is a |
Polymyxin B-containing product in otic dose form |
false |
Inferred relationship |
Some |
|
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
Has manufactured dose form |
Otic dose form (dose form) |
false |
Inferred relationship |
Some |
|
|